73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ
Using mice with humanized immune systems to test cancer immunotherapies

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di
Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the
ACE inhibitor not protective against heart damage from chemotherapy

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin
Bladder cancer treatment can be better targeted and more effective, trials show

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su
How to lower your risk of breast cancer recurrence

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.
New computer platform helps match patients with cancer to trials of targeted therapy

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are
Creating a 'parts list' for cancer's spread, with help from a worm

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put

Creating a 'parts list' for cancer's spread, with help from a worm

by Duke UniversityA tiny worm cell breaking through the wall that normally holds cells in place. Credit:Development(2023). DOI: 10.1242/dev.201570What makes some cancer cells stay put
Researchers discover potential new melanoma treatment, giving hope to patients

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
Drug shows promise as immune therapy for cancer

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese
New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac